Mosquito-Borne Infections Testing Market Seen Reaching $2.12B by 2030

The mosquito-borne infections testing market is projected to grow from $1.56 billion in 2026 to $2.12 billion by 2030 as dengue, malaria and other vector-borne diseases drive demand for faster diagnostics and surveillance. The Business Research Company says climate change, travel, point-of-care testing and multiplex assays are shaping the next phase of growth.

Why it matters: - Mosquito-borne infections testing helps confirm viruses, parasites or bacteria carried by mosquitoes and guides timely treatment. - Faster diagnosis also supports public health response by helping authorities contain outbreaks before they spread. - Rising dengue infections, climate-driven mosquito expansion and more global travel are increasing demand for testing capacity.

What happened: - The Business Research Company published a new mosquito-borne infections testing market report on July 5, 2026. - The report estimates the market will rise from $1.44 billion in 2025 to $1.56 billion in 2026. - The report forecasts the market will reach $2.12 billion by 2030. - The projected 2025-2026 CAGR is 7.8%, and the 2026-2030 CAGR is 8.0%. - The company is offering a free sample of the report. - The company is also offering the full mosquito-borne infections testing market report.

The details: - The report says recent market growth has been driven by dengue and malaria outbreaks, limited access to advanced diagnostics in developing countries, greater awareness of vector-borne disease burdens, expanded laboratory testing in urban health centers and higher government funding for infectious disease control. - Future growth is expected to come from climate change expanding mosquito habitats and transmission zones. - The report points to wider adoption of rapid molecular diagnostics, real-time outbreak tracking, predictive surveillance and integrated public health data reporting systems. - The report also highlights growing demand for personalized and precision diagnostics for infectious diseases. - Key trends include more outbreaks driving demand for quick tests, growth in decentralized and point-of-care testing in remote areas, and greater use of multiplex assays to detect multiple pathogens at once. - Government-led surveillance programs and portable, field-friendly diagnostic kits are also part of the expected shift. - Testing commonly uses blood or serum samples to confirm infection, identify the pathogen and assess disease severity. - The report says this information is critical for targeted treatment and public health interventions. - In July 2023, the World Health Organization reported that Brazil had more than 2.3 million dengue cases through week 26, with 44.2% laboratory-confirmed, a 13% increase from the prior year. - In May 2024, the US National Travel and Tourism Office reported 66.5 million international visitor arrivals in 2023, up by 15.7 million from 2022.

Between the lines: - The market is moving toward faster, decentralized diagnostics because outbreaks are harder to contain when testing is slow or concentrated in major hospitals. - Climate and travel trends are expanding the geographic reach of mosquito-borne disease, which raises the need for surveillance beyond traditional high-burden regions. - The report frames testing as both a clinical tool and a public-health infrastructure play, not just a lab-services market.

What's next: - Asia-Pacific was the largest regional market in 2025. - Latin America is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, hotspot infographics and updated trend analysis. - The Business Research Company lists Saumya Sahay as a media contact at marketing@tbrc.info.

The bottom line: - Mosquito-borne infections testing is shifting from a specialized diagnostic niche to a faster, more distributed public-health necessity as disease patterns widen and surveillance becomes more important.